Oxford Immunotec Global is a diagnostics & research business based in the US. Oxford Immunotec Global shares (OXFD) are listed on the NASDAQ and all prices are listed in US Dollars. Oxford Immunotec Global employs 273 staff and has a trailing 12-month revenue of around $57.3 million.
Our top picks for where to buy Oxford Immunotec Global stock
How to buy Oxford Immunotec Global stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OXFD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Oxford Immunotec Global stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Oxford Immunotec Global stock price (NASDAQ: OXFD)
Use our graph to track the performance of OXFD stocks over time.Oxford Immunotec Global shares at a glance
52-week range | $0.00 - $0.00 |
---|---|
50-day moving average | $21.94 |
200-day moving average | $16.48 |
Wall St. target price | $22.50 |
PE ratio | 11.746 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $5.18 |
Is it a good time to buy Oxford Immunotec Global stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Oxford Immunotec Global stock undervalued or overvalued?
Valuing Oxford Immunotec Global stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Oxford Immunotec Global's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Oxford Immunotec Global's P/E ratio
Oxford Immunotec Global's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Oxford Immunotec Global shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Oxford Immunotec Global financials
Revenue TTM | $57.3 million |
---|---|
Gross profit TTM | $54.4 million |
Return on assets TTM | -4.99% |
Return on equity TTM | -8.19% |
Profit margin | -30.51% |
Book value | $7.37 |
Market Capitalization | $562.5 million |
TTM: trailing 12 months
Oxford Immunotec Global share dividends
We're not expecting Oxford Immunotec Global to pay a dividend over the next 12 months.
Oxford Immunotec Global share price volatility
Over the last 12 months, Oxford Immunotec Global's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oxford Immunotec Global's is 1.3781. This would suggest that Oxford Immunotec Global's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Oxford Immunotec Global overview
Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT. TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT. CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions.
Frequently asked questions
What percentage of Oxford Immunotec Global is owned by insiders or institutions?Currently 1.894% of Oxford Immunotec Global shares are held by insiders and 95.723% by institutions. How many people work for Oxford Immunotec Global?
Latest data suggests 273 work at Oxford Immunotec Global. When does the fiscal year end for Oxford Immunotec Global?
Oxford Immunotec Global's fiscal year ends in December. Where is Oxford Immunotec Global based?
Oxford Immunotec Global's address is: 143 Park Drive, Abingdon, United Kingdom, OX14 4SE What is Oxford Immunotec Global's ISIN number?
Oxford Immunotec Global's international securities identification number is: GB00BGFBB958 What is Oxford Immunotec Global's CUSIP number?
Oxford Immunotec Global's Committee on Uniform Securities Identification Procedures number is: G6855A103
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question